In hepatocellular carcinoma, the insertion of hepatitis B virus enhancers into the host genome activates adjacent genes, such as TERT, KMT2B, and cyclin E1 (CCNE1). The gene discussed is CCNE1; the disease is hepatocellular carcinoma.